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Abstract 
Considering the fear of drug addicts from hangover symptoms and the 
costs of withdrawal treatment and their importance in deciding to 
withdraw, it is helpful to identify various ways of withdrawal and their 
effects. This study investigated the withdrawal symptoms of two 
methods of detoxification with clonidine and rapid detoxification of 
clonidine with naltrexone. 
Background: 
This was a clinical trial study. Patients referred to Shahid Beheshti hos-
pital for narcotic addiction treatment were randomly divided into two 
groups. Group matching was done based on entry and excluding crite-
ria. Data were collected using a demographic questionnaire including 
questions on the drug abuse and the consumption method, and a ques-
tionnaire on the symptoms of opioid withdrawal. 
Methods: 
Restlessness, vomiting, feeling sick and significant decrease of dia-
stolic blood pressure was higher in rapid detoxification method group. 
However, considering background variables, Spearman correlation 
coefficient showed significant relationship just for lacrimation. Temp-
tation for drug consumption was lower for heavy abusers in rapid de-
toxification method and in general, those who had higher amount of 
consumption and were treated by rapid detoxification, experienced 
less temptation for consumption. 
Findings: 
Rapid detoxification can be the first level treatment for heavy abusers, 
because it reduces the temptation for drug consumption and has 
shorter hospitalization and, as a result, has lower cost. 
Conclusion: 
Drug abuse, Rapid detoxification, Clonidine detoxification,  
Withdrawal symptoms. 
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Introduction  
Drug abuse is one of the main health problems in 
Iran and can cause severe and deep physical, psy-
chological and social harms. One of the goals of 
detoxification from drug dependency is to ease or 
remove the pain of withdrawal during the treat-
ment, so that the treatment is safe and can help 
the patient in overcoming drug abuse.1 Drug de-
pendency symptoms are created by stopping con-
sumption or using drug antagonists.2,3 Based on 
the kind of narcotic, symptoms begin after a few 
hours to a few days of consumption cut. Usually, 
narcotics with short term-effect have severe, but 
short term symptoms and those with longer-term 
effect create mild but long term symptoms.4 
 Various methods of treating withdrawal 
symptoms due to detoxification are recommended, 
such as replacing heroin with a narcotic with 
long-term effect like methadone5 or using LAAM 
(levoacethylmetalhadal) and bupronorphine; of 
course, LAAM is not currently available in Iran.6,7 
 Detoxification with above mentioned methods 
is associated with laws and regulations of supply-
ing them, which should be considered as a limita-
tion. 
 Non-opioid treatment approaches to detoxifi-
cation of opioid drugs such as clonidine were 
used in past years.8,9 These days, rapid detoxifica-
tion and even ultra rapid detoxification are con-
sidered as detoxification with opioid in spite of 
their limitations. Some researchers have discussed 
the superiority of rapid method to detoxification 
with clonidine.10,11 
 For rapid and ultra rapid detoxification, 
naloxan, an opioid antagonist with short term 
effects, is used. This method leads to a severe 
withdrawal syndrome that can be treated by con-
stant prescription of clonidine and benzodi-
azepine. In detoxification with clonidine, naltrex-
one is prescribed for at least 5 days in case of 
drugs with short term effects and 10 days for 
drugs with long term effects such as methadone. 
Therefore, in rapid detoxification, detoxification is 
completed within 48 to 72 hours, while it is 7 to 10 
days in other methods.12 Rapid detoxification has 
been used even at home without complications 
and problems.13 
 Ultra rapid detoxification with general anesthe-
sia is also reported in those who have not been 
able to complete their detoxification with other 
methods or those who has severe withdrawal 
symptoms.14 Considering the legal procedure of  
using methadone and bupronorphine in one hand 
and the risk factors of ultra rapid detoxification 
methods on the other hand, this study investi-
gated the treatment of withdrawal symptoms in 
the two methods of detoxification with clonidine 
and naltrexone plus clonidine that do not have 
the above problems. 
 
Methods  
This was a clinical trial study. Participants in-
cluded patients who referred to Shahid Beheshti 
hospital for narcotic addiction treatment. The in-
cluding and excluding criteria were applied (pa-
tients should not have any psychological or 
physical disorder and should not leave the hospi-
tal before all detoxification symptoms are disap-
peared). They also provided a written consent. 
Patients were randomly divided into two groups 
and group matching was based on age, the kind 
of narcotic they used, the method of consumption 
and the amount.  
 After necessary clinical and paraclinical tests 
and considering the medical and psychiatric his-
tory of patients, if there was no problem with de-
toxification with clonidine or clonidine plus 
naltrexone, the patient would be assigned to one 
of the groups. For each group, 30 patients and 30 
questionnaires were filled. 
 Data were collected using a researcher made 
questionnaire including questions on age, career, 
education, number of siblings, birth rank, type of 
addiction, consumption method, amount of con-
sumption, length of addiction and trying with-
drawal. The withdrawal symptoms were assessed 
using St George’s Hospital questionnaire for nar-
cotic withdrawal symptoms. This questionnaire 
includes 13 signs and 12 symptoms.14 The ques-
tionnaires were completed by a trained medical 
intern who was not aware of the patients' treat-
ment method when completing questionnaire. 
 Signs and symptoms were checked and scored 
by an intern through daily clinical examination 
and interview. If there was no sign or symptom, 
the score was 0. In case of mild symptoms or lack 
of evidence about the existence of symptoms the 
score was I and obvious symptoms had score II. 
Signs included yawning, lacrimation, running 
nose, sweating, shaking, piloerection, restlessness, 
pupil size, lack of appetite, vomiting, diarrhea, 
sleeplessness, and trying to get drugs. Symptoms 
included muscle ache, tachycardia, sneezing, feel-
ing pins and needles in body organs, feeling
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Table 1. Frequency distribution and percentage of background variables in the two treatment groups 
 
Type of treatment 
Rapid Traditional 
 
Variable 
 frequency percentage frequency percentage 
Married 13 43.3 13 43.3  Marital status 
Single 17 56.7 17 56.7 
Primary school 2 6.7 4 13.8 
Middle school 8 26.7 15 51.7 
High school 11 36.7 9 31 
Education 
Higher education 9 30 1 3.4 
2 <   1 33.3 5 16.7 
5-2 18 60 11 36.7 
Number of siblings 
5 >   11 36.7 14 46.7 
First 6 20 6 20 Birth rank 
Other 24 80 24 80 
Opium 14 46.7 14 46.7 
Heroin 5 16.7 5 16.7 
Opium and heroin 5 16.7 5 16.7 
Opium and shire 3 10 3 10 
Type of drug 
Shire 3 10 3 10 
Eating 8 26.7 8 26.7 Consumption method 
Smoking 16 53.3 16 53.3 
 Eating and smoking 6 20 6 20 
Unemployed 11 36.7 14 46.7 Job status 
Employed 19 63.3 16 53.3 
1 <  1 3.3 - - Years of consumption 
1 >  29 96.7 30 100 
Yes 23 76.7 24 80 History of withdrawal 
No 7 23. 3 6 20 
 
 cold and hot, muscle cramp, excitability, and 
tendency to take medicine. 
This study was done under the research eth-
ics. 
 
Results 
The mean age of participants was 28.32 ± 5.46 
years. The youngest was 20 year old and the old-
est was 42 years old. The frequency of back-
ground variables is presented in table 1. Most of 
the participants were from crowded families. 20% 
were the first children in the family and 40.7% 
were unemployed. As mentioned before, during 
the study, group matching was tried by recruiting 
more patients. To assure group match, independ-
ent sample t-test was used, which showed no sig-
nificant difference between the two groups (table 
2). Just one of the participants has addiction his-
tory of less than one year. 76.6% of participants in 
rapid detoxification group and 80% of clonidine 
group had a history of detoxification.  
The mean score of 10 days observing signs 
and symptoms for clonidine group and 5 days for 
rapid detoxification group was compared using 
independent sample t-test. Restlessness, vomiting, 
feeling sick, systolic and diastolic blood pressure 
was significantly different between the two 
groups. But there was no significant difference in 
other signs (Table 3). 
 
Table 2. Comparing the mean age and amount of taken narcotics in the two treatment group 
 
variable Treatment method frequency mean Standard deviation results 
Age Rapid 30 28.4 5.77 t = 0.117 
Year Traditional 30 28.2 5.23 p > 0.9 
Amount Rapid 30 3.2 1.77 t = 0.7 
Gram Traditional 30 3.3 8.1 p > 0.9 
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Table 3. The mean of signs and symptoms of withdrawal during treatment period in the two groups 
Treatment method 
Rapid Traditional Variable 
mean Standard deviation mean Standard deviation 
P-value 
Yawning 1.5 0.4 1.42 0.46 0.475 
Lacrimation 1.11 0.49 0.97 0.54 0.29 
Running nose 0.91 0.56 0.74 0.46 0.195 
Sweating 0.7 0.59 0.69 0.57 0.947 
Shaking 0.72 0.61 0.68 0.59 0.818 
Piloerection (sign) 0.41 0.47 0.52 0.47 0.397 
Restlessness 1.19 0.54 0.91 0.52 0.047 
Lack of appetite 0.74 0.54 0.51 0.45 0.07 
Vomiting 0.32 0.43 0.06 0.18 0.004 
Diarrhea 0.57 0.64 0.38 0.37 0.159 
Sleeplessness 0.97 0.7 0.74 0.63 0.187 
Temptation to take drugs 0.45 0.66 0.19 0.32 0.057 
Muscle ache 0.53 0.6 0.83 0.56 0.53 
Heart beat 0.41 0.42 0.37 0.41 0.71 
Sneezing 0.9 0.55 0.69 0.48 0.122 
Pins and needles 0.73 0.61 0.61 0.47 0.411 
Feeling cold and hot 0.98 0.68 0.87 0.58 0.489 
Piloerection (symptom) 0.53 0.54 0.4 0.33 0.292 
Feeling sick 1.03 0.5 0.67 0.38 0.002 
Stomach ache 0.75 0.6 0.62 0.49 0.339 
Musculoskeletal pain 1.06 0.63 1.23 0.51 0.265 
Tremor and muscle cramp 0.65 0.67 0.56 0.54 0.556 
Excitability 0.62 0.83 0.63 0.55 0.971 
Drug seeking behavior 0.36 0.49 0.18 0.27 0.081 
Systolic blood pressure 114 6.26 100.06 5.81 0.000 
Diastolic blood pressure 72 6.34 67.63 5.76 0.002 
Heart beat 84.67 8.21 87.03 4.71 0.179 
 
Discussion 
Comparing the groups, restlessness, feeling sick, 
systolic, and diastolic blood pressure were sig-
nificantly different. Previous studies also re-
ported the severity of withdrawal symptoms.1 
This can be explained considering the consump-
tion of antagonist in one hand and higher con-
sumption of clonidine on the other hand. More-
over, the period of detoxification is also shorter 
both in the present study and in other studies.12 
In other cases, there was no significant differ-
ence. The severity of symptoms was easily con-
trollable by tranquilizer. Since no significant dif-
ference was seen between the type of drug and 
detoxification method, there is no superiority be-
tween these two methods. To our knowledge, 
there are no other studies on the topic to compare. 
In the rapid method group, variables of 
temptation to take drugs and piloerection had a 
negative significant relation with the amount of 
drugs, so that with more amount of consump-
tion the severity of symptoms was decreased. In 
the only clonidine group, the mean severity of 
lacrimation, pins and needles, piloerection and 
tendency to take drugs had a positive significant 
relation with the amount of drugs, so that the 
more drugs, the higher the mean severity of 
these symptoms. It can be concluded that for 
higher amount of drug consumption, the rapid 
detoxification method is superior; because it de-
creases the temptation and sustains withdrawal. 
However, in long term treatment method does 
not have much effect on portent of sustainable 
withdrawal.13 
Considering the results of the study in one 
hand, and the short term hospitalization of pa-
tients on the other hand, which reduces the costs 
and the consumption of narcotics in hospital 
wards, this treatment method can be a suitable 
one for patients who are selected for detoxifica-
tion.  
Limitations: Since patients were different, it was 
possible for them and for other personnel to find 
out about the treatment method. Also, other 
methods of detoxification such as bupronorphine 
and methadone were not compared. 
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  چكيده
هاي درماني بازگيري و اهميت   هزينهنيزم خماري و يبا توجه به ترس بيماران معتاد به مواد مخدر از علا
تواند كمك كننده  هاي مختلف ترك مي  شناخت و تأثير شيوه،گيري براي ترك مواد مخدر يمآن در تصم
از نظر (  سريعييسم زدا) با كلونيدين و كلونيدين با نالتركسون يي دو روش سم زدا، در اين مطالعه.باشد
  .هاي بازگيري مورد بررسي قرار گرفت م و نشانهيعلا
د كه به منظور بودنكنندگان در مطالعه افرادي   شركت،(slairT lacinilC)ي  بالينيياين كار آزمادر   :ها روش
. صورت تصادفي در دو گروه قرار گرفتنده  ب،ترك مواد مخدر به بيمارستان شهيد بهشتي مراجعه كرده
در اين . با توجه به معيارهاي ورود و خروج انجام شد( gnihctam puorG)جور كردن گروهي 
 دموگرافيك كه شامل چگونگي و انواع مصرف نيز بود و پرسشنامه علائم و  پرسشنامه،مطالعه
  .تقرار گرف مورد استفاده هاي بازگيري مواد اپيوئيدي نشانه
داري در گروه  صورت معنيه خون دياستوليك ب قراري، استفراغ، احساس ناخوشي، كاهش فشار بي  :ها يافته
 پس از ارزيابي با ،اي بودند كه اين متغيرها زمينه وجه به اين ولي با ت؛ با روش سريع بيشتر بودييزدا سم
دار وجود  رابطه معني( noitamircaL) فقط در مورد اشك ريزش namraepSآزمون همبستگي 
 ؛ سريع كمتر بودييزدا وسوسه مصرف مواد در مصرف كنندگان شديدتر مواد مخدر در روش سم. داشت
 وسوسه كمتري ، شدندييزدا به هر صورت كساني كه مقدار مصرف زيادتري داشتند و با روش سريع سم
  .براي مصرف مواد داشتند
تواند به   سريع با توجه به كاهش اشتياق به مصرف مواد و كمتر شدن طول مدت بستري ميييزدا سم  :گيري نتيجه
  . مفيد و مقرون به صرفه باشد،ارندعنوان خط اول درمان در معتاداني كه مصرف زياد د
  .هاي ترك  كلونيدين،علائم و نشانهيي سريع، سم زداييمواد مخدر، سم زدا  :واژگان كليدي
  :تعداد صفحات
  :ها تعداد جدول
  :تعداد نمودارها
  :تعداد منابع
  6
  3
  -
  41
، دانشگاه علوم پزشكي كرمانو مركز تحقيقات علوم اعصاب ي پزشكي، دانشكده پزشك روان دانشيار، ينياءالديحسن ضدكتر   :آدرس نويسنده مسؤول
   .رانيكرمان، كرمان، ا
   moc.oohay@iniddaaiz_h :liam-E  
  اعتياد و سلامت  مقاله پژوهشي
 8831  پاييز/2شماره /سال اول  
